tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Novartis AG CAD Hedged CIBC CDR (TSE:NVS)
:NVS
Canadian Market
NVS
Novartis AG CAD Hedged CIBC CDR
RESEARCH TOOLSreports
Advertisement

Novartis AG CAD Hedged CIBC CDR (NVS) Price & Analysis

Compare
― Followers

NVS Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Novartis AG CAD Hedged CIBC CDR News

Novartis price target raised to $143 from $136 at Morgan Stanley
Novartis price target raised to $143 from $136 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Novartis (NVS) to $143 from $136 and keeps an Overweight...
1d ago
NVS
Top drug regulator Richard Pazdur preparing to exit FDA, STAT News reports
Top drug regulator Richard Pazdur preparing to exit FDA, STAT News reports
Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end...
2d ago
AZN
BMY
Vaccine committee considers changes to childhood schedule, NY Times reports
Vaccine committee considers changes to childhood schedule, NY Times reports
Advisers to Health Secretary Robert F. Kennedy Jr. are considering major revisions to the childhood vaccination schedule, including...
2d ago
AZN
BMY
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
The major averages were broadly lower near noon, starting the month in the red as investors await fresh...
3d ago
B
BX
Trump Trade: U.S. confirms agreement with U.K. on pharmaceutical pricing
Trump Trade: U.S. confirms agreement with U.K. on pharmaceutical pricing
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by...
3d ago
AZN
BMY
US government confirms agreement in principle with UK on pharmaceutical pricing
US government confirms agreement in principle with UK on pharmaceutical pricing
The Office of the United States Trade Representative, the Department of Commerce, and the Department of Health and...
3d ago
AZN
BMY
US, UK expected to agree on zero-tariffs pharmaecuticals deal, UK Times says
US, UK expected to agree on zero-tariffs pharmaecuticals deal, UK Times says
The U.K. is close to securing a major pharmaceuticals agreement with Washington that would eliminate U.S. import tariffs...
3d ago
AZN
BMY
Novartis upgraded to Buy from Neutral at BofA
Novartis upgraded to Buy from Neutral at BofA
BofA upgraded Novartis (NVS) to Buy from Neutral with a price target of CHF 117, up from CHF...
9d ago
NVS
Novartis receives FDA approval for Itvisma
Novartis receives FDA approval for Itvisma
Novartis (NVS) “announced that the US Food and Drug Administration has approved Itvisma, onasemnogene abeparvovec-brve, for the treatment...
10d ago
NVS
Labcorp appoints Victor Bulto to Board of Directors
Labcorp appoints Victor Bulto to Board of Directors
Labcorp (LH) announced the appointment of Victor Bulto, a seasoned pharmaceutical executive and member of Novartis’ executive leadership...
10d ago
LH
NVS
Novartis AG: Strong Growth Potential Amid Patent Expirations with Robust Pipeline and Strategic Phase III Trials
Novartis AG: Strong Growth Potential Amid Patent Expirations with Robust Pipeline and Strategic Phase III Trials
In a report released today, Sachin Jain from Bank of America Securities upgraded Novartis AG to a Buy,...
9d ago
NVS
Novartis AG: Hold Rating Amid Moderate Growth and Valuation Concerns
Novartis AG: Hold Rating Amid Moderate Growth and Valuation Concerns
Analyst Sachin Jain of Bank of America Securities reiterated a Hold rating on Novartis AG, retaining the price...
14d ago
NVS
Cautious Hold on Novartis AG Amid Mixed Ianalumab Data and Valuation Concerns
Cautious Hold on Novartis AG Amid Mixed Ianalumab Data and Valuation Concerns
Analyst Sachin Jain of Bank of America Securities maintained a Hold rating on Novartis AG, retaining the price...
1M ago
NVS
Positive Long-Term Growth Outlook for Novartis AG Amid Temporary Setbacks
Positive Long-Term Growth Outlook for Novartis AG Amid Temporary Setbacks
In a report released today, Thibault Boutherin from Morgan Stanley upgraded Novartis AG to a Buy, with a...
1M ago
NVS

NVS FAQ

What was Novartis AG CAD Hedged CIBC CDR’s price range in the past 12 months?
Novartis AG CAD Hedged CIBC CDR lowest stock price was C$23.10 and its highest was C$25.84 in the past 12 months.
    What is Novartis AG CAD Hedged CIBC CDR’s market cap?
    Novartis AG CAD Hedged CIBC CDR’s market cap is C$351.96B.
      When is Novartis AG CAD Hedged CIBC CDR’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Novartis AG CAD Hedged CIBC CDR’s earnings last quarter?
      Currently, no data Available
      Is Novartis AG CAD Hedged CIBC CDR overvalued?
      According to Wall Street analysts Novartis AG CAD Hedged CIBC CDR’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Novartis AG CAD Hedged CIBC CDR pay dividends?
        Novartis AG CAD Hedged CIBC CDR does not currently pay dividends.
        What is Novartis AG CAD Hedged CIBC CDR’s EPS estimate?
        Novartis AG CAD Hedged CIBC CDR’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Novartis AG CAD Hedged CIBC CDR have?
        Novartis AG CAD Hedged CIBC CDR has 2,112,421,900 shares outstanding.
          What happened to Novartis AG CAD Hedged CIBC CDR’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Novartis AG CAD Hedged CIBC CDR?
          Currently, no hedge funds are holding shares in TSE:NVS
          Similar Stocks
          Company
          Price & Change
          Follow
          BHC
          Bausch Health Companies
          ―
          ―
          ROG
          Roche Holding Ltd CAD Hedged CIBC CDR
          ―
          ―
          Compare TSE:NVS Stocks >
          Popular Stocks

          Become an Expert with TipRanks Premium

          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis
          Subscribe NowSee Plans & Pricing